“…However, a number of reports of identification of structurally distinct non-AHL analogous molecules as QS inhibitors (Müh et al, 2006;Sabbah et al, 2012;Riedel et al, 2006;Park et al, 2006;Degrassi et al, 2002;Jadhav et al, 2011) which bind with the receptor in a non-competitive fashion and thus retards QS signalling. These categories include inhibitors carrying non-AHL core of tetrazole (Müh et al, 2006), thiophene (Riedel et al, 2006), cyclic dipeptides (2,5 diketopiperazines) (Park et al, 2006;Degrassi et al, 2002), novel triphenyl scaffold (Campbell et al, 2009) and some small molecules with electrophilic functionalities (isothiocyanates, haloacetamides, etc.)…”